ELAN - Elanco Animal Health Incorporated
NEXT EARNINGS:
May 5, 2026
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$27.63
DETAILS
HIGH:
$30.00
LOW:
$22.00
MEDIAN:
$28.50
CONSENSUS:
$27.63
UPSIDE:
4.74%
Market Cap:
13.11B
Volume:
8,563,968
Avg Volume:
4,964,840
52 Week Range:
8.02-26.87
Sector:
Healthcare
Industry:
Drug Manufacturers - Specialty & Generic
Beta:
1.86
Last Dividend:
$N/A
Exchange:
NYSE
Country:
US
Employees:
9,000
IPO Date:
2018-09-20
EPS (TTM):
-0.47
P/E Ratio:
-48.42
Revenue (TTM):
4.71B
Total Assets:
13.36B
Total Debt:
4.02B
Cash & Equiv:
545.00M
Rev Growth (5Y):
7.6%
EPS Growth (5Y):
30.4%
FCF Growth (5Y):
22.5%
ROCE:
N/A
Debt/Equity:
0.61
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2025-11-05 | $0.19 | $0.13 | +46.2% | $1.1B | $1.1B | +4.1% |
| 2025-08-07 | $0.26 | $0.20 | +30.0% | $1.2B | $1.1B | +13.9% |
| 2025-05-07 | $0.37 | $0.31 | +19.4% | $1.2B | $1.2B | +1.3% |
| 2025-02-25 | $0.14 | $0.16 | -12.5% | $1.0B | $1.2B | -15.7% |
| 2024-11-07 | $0.13 | $0.12 | +8.3% | $1.0B | $1.0B | +1.7% |
| 2024-08-08 | $0.30 | $0.24 | +25.0% | $1.2B | $1.2B | +2.8% |
| 2024-05-08 | $0.34 | $0.27 | +24.1% | $1.2B | $1.2B | +1.4% |
| 2024-02-26 | $0.08 | $0.10 | -20.0% | $1.0B | $1.0B | +3.3% |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 4.71B | 4.44B | 4.42B | 4.41B | 4.76B | 3.27B | 3.07B | 3.07B | 2.89B | 2.91B | 2.91B |
| Net Income | (232.00M) | 338.00M | (1.23B) | (78.00M) | (483.00M) | (560.10M) | 67.90M | 86.50M | (310.70M) | (47.90M) | (210.80M) |
| EPS | -0.47 | 0.68 | -2.50 | -0.15 | -0.97 | -1.27 | 0.18 | 0.28 | -0.87 | -0.13 | -0.59 |
| Total Assets | 13.36B | 12.61B | 14.36B | 15.49B | 16.48B | 17.69B | 8.99B | 8.96B | 8.94B | 8.10B | N/A |
| Total Debt | 4.02B | 4.32B | 5.77B | 5.84B | 6.32B | 6.13B | 2.35B | 2.47B | 0 | 0 | N/A |
| Cash & Equivalents | 545.00M | 468.00M | 352.00M | 345.00M | 638.00M | 495.00M | 334.00M | 474.80M | 323.40M | 258.80M | N/A |
| Operating Cash Flow | 560.00M | 541.00M | 271.00M | 452.00M | 483.00M | (41.00M) | 224.10M | 487.30M | 173.80M | 155.90M | 6.60M |
| Free Cash Flow | 284.00M | 394.00M | 117.00M | 268.00M | 286.00M | (351.90M) | 26.70M | 352.80M | 75.20M | 45.60M | (93.50M) |
| FCF per Share | 0.57 | 0.80 | 0.24 | 0.55 | 0.59 | -0.80 | 0.07 | 1.12 | 0.21 | 0.13 | -0.26 |
| Book Value | 6.55B | 6.10B | 6.22B | 7.29B | 7.51B | 8.48B | 5.55B | 5.20B | 7.79B | 7.03B | N/A |
| Cash & ST Investments | 545.00M | 468.00M | 352.00M | 345.00M | 638.00M | 495.00M | 334.00M | 474.80M | 323.40M | 258.80M | N/A |
| ROC Equity | -0.04 | 0.06 | -0.20 | -0.01 | -0.06 | -0.07 | 0.01 | 0.02 | -0.04 | -0.01 | N/A |